Bonsack Frederick, Alleyne Cargill H, Sukumari-Ramesh Sangeetha
Department of Neurosurgery, Medical College of Georgia, Augusta University, 1120 15th Street, CA1010, Augusta, GA, 30912, USA.
J Neuroinflammation. 2016 Jun 17;13(1):151. doi: 10.1186/s12974-016-0619-2.
Intracerebral hemorrhage (ICH) is a potentially fatal stroke subtype accounting for 10-15 % of all strokes. Despite neurosurgical intervention and supportive care, the 30-day mortality rate remains 30-50 % with ICH survivors frequently displaying neurological impairment and requiring long-term assisted care. Although accumulating evidence demonstrates the role of neuroinflammation in secondary brain injury and delayed fatality after ICH, the molecular regulators of neuroinflammation remain poorly defined after ICH.
In the present study, ICH was induced in CD1 male mice by collagenase injection method and given the emerging role of TSPO (18-kDa translocator protein) in neuroinflammation, immunofluorescence staining of brain sections was performed to characterize the temporal expression pattern and cellular and subcellular localization of TSPO after ICH. Further, both genetic and pharmacological studies were employed to assess the functional role of TSPO in neuroinflammation.
The expression of TSPO was found to be increased in the peri-hematomal brain region 1 to 7 days post-injury, peaking on day 3 to day 5 in comparison to sham. Further, the TSPO expression was mostly observed in microglia/macrophages, the inflammatory cells of the central nervous system, suggesting an unexplored role of TSPO in neuroinflammatory responses after ICH. Further, the subcellular localization studies revealed prominent perinuclear expression of TSPO after ICH. Moreover, both genetic and pharmacological studies revealed a regulatory role of TSPO in the release of pro-inflammatory cytokines in a macrophage cell line, RAW 264.7.
Altogether, the data suggest that TSPO induction after ICH could be an intrinsic mechanism to prevent an exacerbated inflammatory response and raise the possibility of targeting TSPO for the attenuation of secondary brain injury after ICH.
脑出血(ICH)是一种潜在致命的中风亚型,占所有中风的10 - 15%。尽管有神经外科干预和支持性护理,但脑出血患者的30天死亡率仍为30 - 50%,幸存者常表现出神经功能障碍并需要长期辅助护理。虽然越来越多的证据表明神经炎症在脑出血后的继发性脑损伤和延迟死亡中起作用,但脑出血后神经炎症的分子调节因子仍不清楚。
在本研究中,通过胶原酶注射法在CD1雄性小鼠中诱导脑出血,并鉴于转运蛋白18kDa(TSPO)在神经炎症中的新作用,对脑切片进行免疫荧光染色,以表征脑出血后TSPO的时间表达模式以及细胞和亚细胞定位。此外,采用基因和药理学研究来评估TSPO在神经炎症中的功能作用。
发现损伤后1至7天,血肿周围脑区TSPO的表达增加,与假手术组相比,在第3至5天达到峰值。此外,TSPO表达主要在小胶质细胞/巨噬细胞中观察到,它们是中枢神经系统的炎症细胞,这表明TSPO在脑出血后的神经炎症反应中具有尚未被探索的作用。此外,亚细胞定位研究显示脑出血后TSPO在细胞核周围有明显表达。而且,基因和药理学研究均揭示TSPO在巨噬细胞系RAW 264.7中对促炎细胞因子的释放具有调节作用。
总之,数据表明脑出血后TSPO的诱导可能是一种内在机制,以防止炎症反应加剧,并增加了将TSPO作为靶点减轻脑出血后继发性脑损伤的可能性。